UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000009639 |
|---|---|
| Receipt number | R000011264 |
| Scientific Title | Efficacy study of sequential therapy with anthracycline, taxane, and eribulin in patients with HER2-negative locally advanced breast cancer (JBCRG-17) |
| Date of disclosure of the study information | 2012/12/28 |
| Last modified on | 2021/11/09 14:30:41 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2012/12/26 20:33:44 | ||
| 2 | Update | 2013/01/02 22:47:57 | Condition Key secondary outcomes |
|
| 3 | Update | 2013/06/14 16:28:41 | Recruitment status |
|
| 4 | Update | 2013/06/27 14:59:29 | Institutions |
|
| 5 | Update | 2014/01/28 13:48:20 | Division name Institutions |
|
| 6 | Update | 2014/07/29 09:39:01 | Address Address TEL Address Address TEL |
|
| 7 | Update | 2014/07/29 09:41:14 | Last follow-up date |
|
| 8 | Update | 2014/12/26 09:31:01 | Recruitment status Last follow-up date |
|
| 9 | Update | 2014/12/26 09:37:50 | Institutions |
|
| 10 | Update | 2016/06/28 10:42:05 | Name of primary person or sponsor Organization |
|
| 11 | Update | 2018/08/24 10:07:30 | UMIN ID1 UMIN ID2 |
|
| 12 | Update | 2019/09/05 14:46:48 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Address Address TEL Last name of contact person Last name of contact person Zip code Address Address Organization Organization Address Address Tel |
|
| 13 | Update | 2019/09/05 14:48:36 | Number of participants that the trial has enrolled Results Delayed Results Delay Reason Results Delay Reason |
|
| 14 | Update | 2019/09/05 14:49:52 | Number of participants that the trial has enrolled |
|
| 15 | Update | 2019/09/05 14:50:23 | Date of IRB |
|
| 16 | Update | 2021/07/08 15:58:20 | Recruitment status Last follow-up date |
|
| 17 | Update | 2021/11/09 14:25:51 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Results Delayed Results Delay Reason Results Delay Reason Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
| 18 | Update | 2021/11/09 14:30:41 | Last name of contact person Last name of contact person Homepage URL Name of person sending information Name of person sending information |
